• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Level Bio

0.26 SEK

-12.08 %

Less than 1K followers

LEVBIO

NGM Growth Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-12.08 %
-14.94 %
-28.80 %
-12.67 %
-17.09 %
-12.67 %
-64.69 %
-84.82 %
-97.37 %

Level Bio is active in medical technology that develops, manufactures and distributes innovative diagnostics. The company's products are sold under several brands and through its own distributors, mainly to laboratories and research institutes. The company's largest operations are found in the Nordic market. Level Bio is headquartered in Stockholm.

Read more
Market cap
17.92M SEK
Turnover
7.02K SEK
Revenue
32.36M
EBIT %
-10.78 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
20/8
2026

Interim report Q2'26

22/10
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release6/17/2026, 4:45 AM

Level Bio AB: Level Bios dotterbolag Techtum Lab har fått en order för instrumentet iconPCR med värde om ca 1,2 msek

Level Bio
Regulatory press release5/21/2026, 6:51 AM

Level Bio AB: Level Bio marknadsuppdatering

Level Bio
Regulatory press release5/20/2026, 2:22 PM

Kommuniké från årsstämma i Level Bio AB (publ)

Level Bio

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/29/2026, 3:30 PM

Level Bio AB: Level Bio publicerar årsredovisning för 2025

Level Bio
Press release4/23/2026, 6:27 AM

Quanor: Level Bio ökar omsättningen med 15 procent i Q1 och slutför avyttring av CyberGene

Level Bio
Regulatory press release4/23/2026, 6:15 AM

Delårsrapport för första kvartalet 2026 Level Bio AB (publ)

Level Bio
Regulatory press release4/20/2026, 1:53 PM

Level Bio AB: Inbjudan till presentation av Level Bios rapport för första kvartalet 2026

Level Bio
Regulatory press release4/16/2026, 6:00 AM

KALLELSE TILL ÅRSSTÄMMA i Level Bio AB (publ)

Level Bio
Regulatory press release4/1/2026, 8:15 AM

Level Bio AB: Level Bio har genomfört avyttringen av dotterbolaget CyberGene AB

Level Bio
Regulatory press release2/19/2026, 7:15 AM

Bokslutskommuniké 2025 Level Bio AB (publ)

Level Bio
Regulatory press release2/16/2026, 3:03 PM

Level Bio AB: Inbjudan till presentation av Level Bios bokslutskommuniké 2025

Level Bio
Regulatory press release2/11/2026, 7:05 PM

Level Bio AB: Devyser förvärvar Level Bios dotterbolag CyberGene

Level Bio
Press release12/11/2025, 2:00 PM

Kalqyl: Level Bio: NGM Company Insights

Level Bio
Regulatory press release11/26/2025, 4:15 PM

Level Bio AB: Level Bios dotterbolag Techtum Lab har vunnit en första upphandling för instrumentet iconPCR med värde om ca 1,4 msek

Level Bio
Regulatory press release10/23/2025, 6:15 AM

Delårsrapport för tredje kvartalet 2025 Level Bio AB (publ)

Level Bio
Regulatory press release10/17/2025, 11:36 AM

Level Bio AB: Inbjudan till presentation av Level Bios Q3-rapport 2025

Level Bio
Regulatory press release8/21/2025, 6:15 AM

Delårsrapport för andra kvartalet 2025 Level Bio AB (publ)

Level Bio
Regulatory press release8/19/2025, 7:25 AM

Level Bio AB: Presentation av Level Bios Q2-rapport 2025

Level Bio
Regulatory press release8/18/2025, 10:55 AM

Level Bio AB: Level Bios dotterbolag Techtum Lab har fått en order med ett ordervärde om ca 1,5 MSEK

Level Bio
Regulatory press release6/10/2025, 2:30 PM

Level Bio AB: Level Bios dotterbolag Techtum Lab har mottagit certifiering enligt standarden ISO 9001:2015

Level Bio